Westlake Chemical Corporation (WLK)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $8.13B
Last updated: Nov 17, 2026 at 11:06 AM ET
Westlake Chemical Corporation (WLK) Financials: Revenue, Profit and Cash Flow
Westlake Chemical reported revenue of $11.17B for the fiscal year ended Dec 31, 2025, down 8.0% from the year before. That year, net income was -$1.47B with a net margin of -13.2%, operating cash flow was $465.00M and free cash flow was -$530.00M. The quarter ended Sep 30, 2026 had revenue of $2.98B and net income of $18.00M.
Revenue and Margins
The operating margin was -14.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $5.08B, a compound annual rate of 9.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $11.17B | -8.0% | 7.3% | -14.1% | -13.2% |
| Dec 2024 | $12.14B | -3.2% | 16.1% | 7.2% | 5.3% |
| Dec 2023 | $12.55B | -20.6% | 17.7% | 5.8% | 4.2% |
| Dec 2022 | $15.79B | +34.1% | 25.8% | 19.3% | 14.5% |
| Dec 2021 | $11.78B | +57.0% | 29.7% | 23.8% | 17.6% |
| Dec 2020 | $7.50B | -7.6% | 13.6% | 5.7% | 5.0% |
| Dec 2019 | $8.12B | -6.0% | 15.5% | 8.1% | 5.7% |
| Dec 2018 | $8.63B | +7.4% | 23.0% | 16.3% | 12.0% |
| Dec 2017 | $8.04B | +58.4% | 21.9% | 15.2% | 16.7% |
| Dec 2016 | $5.08B | N/A | 19.4% | 11.5% | 8.3% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.17B | $12.14B | $12.55B | $15.79B | $11.78B | $7.50B | $8.12B | $8.63B | $8.04B | $5.08B |
| Cost of revenue | $10.36B | $10.19B | $10.33B | $11.72B | $8.28B | $6.48B | $6.86B | $6.65B | $6.28B | $4.09B |
| Gross profit | $813.00M | $1.96B | $2.22B | $4.07B | $3.50B | $1.02B | $1.26B | $1.99B | $1.76B | $983.00M |
| Operating income | -$1.58B | $875.00M | $729.00M | $3.05B | $2.80B | $429.00M | $656.00M | $1.41B | $1.23B | $583.00M |
| Net income | -$1.47B | $647.00M | $522.00M | $2.30B | $2.07B | $373.00M | $462.00M | $1.03B | $1.34B | $420.00M |
| EBITDA | -$248.00M | $2.21B | $1.96B | $4.18B | $3.69B | $1.25B | $1.41B | $2.10B | $1.84B | $1.01B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.98B | $3.27B | $2.65B | $2.53B | $2.84B | $2.95B | $2.85B | $2.84B | $3.12B | $3.21B | $2.98B | $2.83B |
| Gross profit | $382.00M | $652.00M | $112.00M | $87.00M | $236.00M | $258.00M | $232.00M | $328.00M | $499.00M | $664.00M | $466.00M | $199.00M |
| Operating income | $43.00M | $364.00M | -$172.00M | -$671.00M | -$766.00M | -$109.00M | -$32.00M | $66.00M | $180.00M | $406.00M | $223.00M | -$552.00M |
| Net income | $18.00M | $271.00M | -$157.00M | -$533.00M | -$772.00M | -$131.00M | -$35.00M | $19.00M | $120.00M | $323.00M | $185.00M | -$487.00M |
Balance Sheet
As of Dec 2025, total debt of $5.58B exceeded cash and equivalents by $2.86B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $19.96B | $20.75B | $21.04B | $20.55B | $18.46B | $13.84B | $13.26B | $11.60B | $12.08B | $10.89B |
| Current assets | $6.22B | $6.21B | $6.61B | $5.97B | $5.26B | $3.48B | $2.74B | $2.84B | $3.46B | $2.41B |
| Cash and equivalents | $2.72B | $2.92B | $3.30B | $2.23B | $1.91B | $1.31B | $728.00M | $753.00M | $1.53B | $459.00M |
| Total liabilities | $10.67B | $9.71B | $10.27B | $10.09B | $9.93B | $7.26B | $6.86B | $5.53B | $6.71B | $7.00B |
| Short-term debt | $497.00M | $6.00M | $299.00M | $0 | $269.00M | $0 | $119.00M | $0 | $710.00M | $149.00M |
| Long-term debt | $5.09B | $4.56B | $4.61B | $4.88B | $4.91B | $3.57B | $3.44B | $2.67B | $3.13B | $3.68B |
| Shareholder equity | $8.79B | $10.53B | $10.24B | $9.93B | $7.96B | $6.04B | $5.86B | $5.59B | $4.87B | $3.52B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $19.27B | $19.44B | $19.71B | $19.96B | $19.81B | $20.81B | $20.71B | $20.75B | $21.11B | $21.08B | $20.96B | $21.04B |
| Total liabilities | $10.11B | $10.23B | $10.66B | $10.67B | $9.88B | $10.02B | $9.79B | $9.71B | $9.92B | $9.99B | $10.11B | $10.27B |
| Cash and equivalents | $1.76B | $1.64B | $2.27B | $2.72B | $1.93B | $2.08B | $2.30B | $2.92B | $2.92B | $3.04B | $3.11B | $3.30B |
| Shareholder equity | $8.66B | $8.71B | $8.55B | $8.79B | $9.43B | $10.28B | $10.41B | $10.53B | $10.66B | $10.57B | $10.33B | $10.24B |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $465.00M | $1.31B | $2.34B | $3.40B | $2.39B | $1.30B | $1.30B | $1.41B | $1.53B | $867.00M |
| Capital expenditures | $995.00M | $1.01B | $1.03B | $1.11B | $658.00M | $525.00M | $787.00M | $702.00M | $577.00M | $629.00M |
| Free cash flow | -$530.00M | $306.00M | $1.30B | $2.29B | $1.74B | $772.00M | $514.00M | $707.00M | $951.00M | $238.00M |
| Dividends paid | $323.00M | $313.00M | $275.00M | $229.00M | $193.00M | $192.00M | $182.00M | $165.00M | $131.00M | $114.00M |
| Share repurchases | $63.00M | $60.00M | $23.00M | $101.00M | $30.00M | $54.00M | $30.00M | $106.00M | $0 | $67.00M |
| Investing cash flow | -$1.22B | -$1.00B | -$1.04B | -$2.48B | -$3.21B | -$509.00M | -$1.95B | -$754.00M | -$652.00M | -$2.56B |
| Financing cash flow | $530.00M | -$650.00M | -$245.00M | -$587.00M | $1.44B | -$216.00M | $630.00M | -$1.43B | $6.00M | $1.69B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $395.00M | $318.00M | -$94.00M | $225.00M | $182.00M | $135.00M | -$77.00M | $434.00M | $474.00M | $237.00M | $169.00M | $573.00M |
| Capital expenditures | $175.00M | $207.00M | $209.00M | $241.00M | $239.00M | $267.00M | $248.00M | $285.00M | $220.00M | $231.00M | $272.00M | $282.00M |
| Free cash flow | $220.00M | $111.00M | -$303.00M | -$16.00M | -$57.00M | -$132.00M | -$325.00M | $149.00M | $254.00M | $6.00M | -$103.00M | $291.00M |
Frequently Asked Questions About WLK
What is Westlake Chemical's annual revenue?
Westlake Chemical reported revenue of $11.17B for the fiscal year ended Dec 31, 2025.
How fast is Westlake Chemical's revenue growing?
Revenue was down 8.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -10.9%.
Is Westlake Chemical profitable?
No. Westlake Chemical reported net income of -$1.47B for the fiscal year ended Dec 31, 2025, with a net margin of -13.2%.
How much free cash flow does WLK generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $465.00M minus capital expenditures of $995.00M produced free cash flow of -$530.00M.
How much debt does Westlake Chemical have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $5.09B, short-term debt of $497.00M and cash and equivalents of $2.72B.
WLK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors